Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

News: Cancer Research

Exploring Accountable Care Organizations’ impact on cancer screenings

Friday, May 29th, 2015

As health care organizations implement new strategies to improve quality and reduce costs, a physician researcher at VUMC is setting out to identify whether there could be unintended effects. Matthew Resnick, M.D., MPH, assistant professor of Urologic Surgery and Health Policy, has been awarded a $726,000 grant from the American Cancer Society to study the […]

Tools for exploring ‘omics’ data

Thursday, May 21st, 2015

Advances in technology have generated vast amounts of “omics” data: genomic, epigenomic, transcriptomic, proteomic and metabolomic changes for all types of specimens. Bridging the gap between data generation and investigators’ ability to retrieve and interpret data is essential to realize the biological and clinical value of this wealth of information. Bing Zhang, Ph.D., and colleagues […]

VICC Annual Retreat focuses on immunotherapy

Thursday, May 21st, 2015

Cancer cells multiply, spread and thrive in large measure because the body’s immune system doesn’t recognize the cancer as a lethal threat. Efforts to enable the immune system to “see” the cancer and attack the aberrant cells were the prime focus during Vanderbilt-Ingram Cancer Center’s Annual Retreat, held April 30 at the Vanderbilt University Student […]

Jansen’s cancer research efforts garner recognition

Thursday, May 14th, 2015

Valerie Malyvanh Jansen, M.D., Ph.D., a third-year medical oncology fellow, recently received several national awards and grants, as well as a Vanderbilt-Ingram Cancer Center fellowship, in recognition of her translational cancer research. Jansen received an American Association for Cancer Research (AACR) 2015 Women in Cancer Research Scholars Award. The awards are given to members of […]

Supportive environment spurs Biomedical Sciences graduates

Thursday, May 14th, 2015

“It takes a village to raise a scientist.” That’s how Shenika Poindexter describes Vanderbilt University’s approach to graduate training in the biomedical sciences. “I had a lot of help,” said Poindexter, who celebrated her recently minted Ph.D. in Cancer Biology at the Graduate School’s Commencement ceremony last week. The support provided by faculty mentors and […]

Discovery Lecture to feature VICC experts

Thursday, May 14th, 2015

Three Vanderbilt University scientists will describe “gene-environment interactions in cancer etiology and prevention” at 4 p.m. Thursday, May 21, in 208 Light Hall. The panel discussion of “cutting-edge discovery” at Vanderbilt is the final Flexner Discovery Lecture of the 2014-2015 academic year. Speakers include: • Robert J. Coffey Jr., M.D., Ingram Professor of Cancer Research, professor […]

VICC research efforts in spotlight at AACR conference

Thursday, April 30th, 2015

Adding an investigational drug to an already approved estrogen blocking therapy appears to be safe and provided clinical benefit for some postmenopausal women with estrogen-positive breast cancer. The research led by Ingrid Mayer, M.D., associate professor of Medicine and clinical director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), was selected for the […]

Best hospital depends on cancer type

Thursday, April 23rd, 2015

The idea of a “Best Hospital for Cancer” does not reflect the fact that cancer comprises many different diseases. Jeffery Goldstein, M.D., Ph.D., a resident in the Department of Pathology, Microbiology and Immunology at Vanderbilt, and Vinay Prasad, M.D., MPH, aimed to rank the 50 highest ranked cancer hospitals – from the 2013 U.S. News […]

Statin use improves renal cell cancer survival

Friday, April 17th, 2015

A new study led by Vanderbilt University investigators found that patients being treated with statins at the time of surgery for kidney cancer, also known as renal cell carcinoma, had improved overall survival and disease-specific survival. Drugs known as statins are widely used to lower cholesterol and previous studies have indicated that they could be […]

Cancer signaling pathway blocker

Friday, April 10th, 2015

Researchers at Vanderbilt University have discovered a new way to inhibit Hedgehog (Hh) signaling, an important regulatory pathway for vertebrate development – and cancer. Abnormal regulation of this pathway leads to several human malignancies, including small cell lung cancer and pancreatic cancer, and therefore it is a potential drug target for cancer. Small molecules have […]

Next Page »« Previous Page